These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5730901)

  • 1. Effect of cholestyramine on cholesterol gallstones in mice.
    Bergman F; van der Linder W
    Acta Chir Scand; 1968; 134(3):287-90. PubMed ID: 5730901
    [No Abstract]   [Full Text] [Related]  

  • 2. Change of bile composition in man after administration of cholestyramine (a gallstone dissolving agent in hamsters).
    van der Linden W; Nakayama F
    Acta Chir Scand; 1969; 135(5):433-8. PubMed ID: 5357672
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum cholesterol and cholelithias in rabbits treated with pectin and cholestyramine.
    Borgman RF; Wardlaw FB
    Am J Vet Res; 1974 Nov; 35(11):1445-7. PubMed ID: 4429245
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical treatment of retained gallstones.
    Admirand WH; Way L
    Trans Assoc Am Physicians; 1972; 85():382-7. PubMed ID: 4660017
    [No Abstract]   [Full Text] [Related]  

  • 5. [The dissolving capacity of secreted bile during cholestyramine medication for human gallstones and artificially produced cholesterol concrements].
    Holub K
    Langenbecks Arch Chir; 1969; 325():584-8. PubMed ID: 5372371
    [No Abstract]   [Full Text] [Related]  

  • 6. Dissolution of cholesterol gallstones in mice by the oral administration of a fatty acid bile acid conjugate.
    Gilat T; Leikin-Frenkel A; Goldiner I; Halpern Z; Konikoff FM
    Hepatology; 2002 Mar; 35(3):597-600. PubMed ID: 11870372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts of gallstone formation.
    Morrissey KP
    Major Probl Clin Surg; 1975; 16():14-34. PubMed ID: 1099341
    [No Abstract]   [Full Text] [Related]  

  • 8. Dissolving gall stones.
    Br Med J; 1972 Feb; 1(5799):525. PubMed ID: 5015044
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved lithogenicity of fasting hepatic bile by dietary fiber and cholestyramine: studies in mice and humans.
    Hall RC; Klauda HC; Waite VM; Friedman A; Feher J; Tepperman J
    Surg Forum; 1975; 26():435-7. PubMed ID: 1216185
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the problem of "solubility" of gallstones in bile].
    Holub K
    Wien Klin Wochenschr; 1969 Feb; 81(7):125-6. PubMed ID: 5784869
    [No Abstract]   [Full Text] [Related]  

  • 11. Alimentary production of gallstones in hamsters. 22. The influence of a non-absorbable bile acid binding resin, cholestyramine, on formation of gallstones in hamsters.
    Sondergaard E; Prange I; Dam H
    Z Ernahrungswiss; 1969 Mar; 9(2):174-9. PubMed ID: 5796638
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI.
    Jolley CD; Dietschy JM; Turley SD
    Hepatology; 2000 Dec; 32(6):1309-16. PubMed ID: 11093738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interrelations between biliary lithiasis and hepatic cirrhosis].
    De Martiis M; Patrizi P; Romagnino F; D'Ottavi R; De Martiis A
    Clin Ter; 1985 Nov; 115(4):243-51. PubMed ID: 4085180
    [No Abstract]   [Full Text] [Related]  

  • 14. Gallstone formation in guinea pigs under different dietary conditions. Effect of vitamin C on bile acid pattern.
    Bergman F; Curstedt T; Eriksson H; van der Linden W; Sjövall J
    Med Biol; 1981 Apr; 59(2):92-8. PubMed ID: 7311630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of diet-induced fatty liver in experimental animals by the oral administration of a fatty acid bile acid conjugate (FABAC).
    Gilat T; Leikin-Frenkel A; Goldiner I; Juhel C; Lafont H; Gobbi D; Konikoff FM
    Hepatology; 2003 Aug; 38(2):436-42. PubMed ID: 12883488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cholestyramine on bile composition and gallstones in hamsters and in man.
    Van der Linden W; Bergman F; Nakayama F
    Tijdschr Gastroenterol; 1969; 12(4):337-47. PubMed ID: 5362130
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Cholestyramine therapy in cholestatic liver disease of children.
    Nelson R; Murphy GM; Edkins S; Nutter S; Anderson CM
    Gut; 1974 Oct; 15(10):825. PubMed ID: 4434934
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholelithiasis in rabbits: effects of several treatments on formation and dissolution of gallstones.
    Borgman RF; Haselden FH
    Am J Vet Res; 1969 Nov; 30(11):1979-84. PubMed ID: 5347105
    [No Abstract]   [Full Text] [Related]  

  • 19. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones.
    Amigo L; Castro J; Miquel JF; Zanlungo S; Young S; Nervi F
    Gastroenterology; 2006 Dec; 131(6):1870-8. PubMed ID: 17064699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Innovations in the medical treatment of gallstones and fatty liver: FABACs (Fatty Acid Bile Acid Conjugates)].
    Keizman D; Goldiner I; Leikin-Frenkel A; Konikoff FM
    Harefuah; 2008 Apr; 147(4):344-9, 373, 372. PubMed ID: 18686819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.